AGEN – agenus inc. (US:NASDAQ)
Stock Stats
News
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript [Seeking Alpha]
Agenus (NASDAQ:AGEN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL [Yahoo! Finance]
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
Form 4 AGENUS INC For: Dec 12 Filed by: ARMEN GARO H
Form 4 AGENUS INC For: Nov 28 Filed by: ARMEN GARO H
Form 4 AGENUS INC For: Nov 14 Filed by: ARMEN GARO H
Form 10-Q AGENUS INC For: Sep 30
Form 8-K AGENUS INC For: Nov 10
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.